SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000947871-23-000180
Filing Date
2023-02-14
Accepted
2023-02-14 16:43:21
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss1758599_sc13g.htm SC 13G 50017
2 JOINT FILING AGREEMENT ss1758599_ex99a.htm EX-99.A 5946
  Complete submission text file 0000947871-23-000180.txt   57546
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 23630656
SIC: 2834 Pharmaceutical Preparations